Mid-point Transverse Process to Pleura Block Versus Thoracic Paravertebral Block in Posterolateral Thoracotomy
Launched by FAYOUM UNIVERSITY HOSPITAL · Apr 7, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of providing pain relief for patients undergoing a specific type of chest surgery called posterolateral thoracotomy. The two methods being compared are the Thoracic Paravertebral Block (TPV) and a newer approach called the Mid-point Transverse Process to Pleura Block (MTP). Both techniques involve injecting a local anesthetic to help numb the area around the spine, but the MTP block is designed to be safer and easier to perform. The goal is to see if the MTP block can provide pain relief that is just as effective as the TPV block for patients with conditions like bronchiectasis, lung tumors, or emphysema.
To be eligible for this study, participants should be adults scheduled for planned thoracic surgery, and they should be in good overall health with manageable medical conditions. Some factors that would exclude someone from participating include significant kidney or heart problems, allergies to the medications used in the study, or certain other health issues. If you join the study, you can expect to receive either of the two pain relief techniques during your surgery, and the effectiveness of your pain management will be monitored afterward. This trial is currently looking for participants and aims to improve pain management for patients undergoing these types of surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients Scheduled for elective thoracic surgery for pneumectomy, lobectomy, bullectomy or pleural decortication via posterolateral thoracotomy incision.
- • American Society of Anesthesiologists (ASA) physical status I-III patients
- Exclusion Criteria:
- • Patient refusal.
- • Significant renal, hepatic and cardiovascular diseases.
- • History of allergy to one of the study drugs.
- • Any contraindication to regional anesthesia such as local infection or bleeding disorders.
- • Chronic opioid use, history of chronic pain and cognitive disorders.
- • Emergent or re-do surgeries
About Fayoum University Hospital
Fayoum University Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor of clinical research, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to support the development of new therapies and treatments. With a commitment to ethical standards and patient safety, Fayoum University Hospital collaborates with a network of researchers and healthcare professionals to foster scientific discovery and enhance clinical outcomes. Its strategic focus on community health and education positions it as a vital contributor to the evolving landscape of medical research in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fayoum, , Egypt
Patients applied
Trial Officials
Mohamed A Hamed, MD
Principal Investigator
Fayoum University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported